Skip to main content
Log in

Role of IGFBP6 Protein in the Regulation of Epithelial-Mesenchymal Transition Genes

  • GENETICS
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Protein IGFBP6 plays an important role in the pathogenesis of many malignant tumors, including breast cancer. The relationship between IGFBP6 protein and the expression of genes associated with the epithelial-mesenchymal transition is studied. Gene IGFBP6 knockdown does not trigger the epithelial-mesenchymal transition in MDA-MB-231 cells, but modifies significantly the expression of many genes involved in this process. A decrease of IGFBP6 expression can involve a decrease in the expression of N-cadherin and transcription factor Slug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bach LA. Current ideas on the biology of IGFBP-6: More than an IGF-II inhibitor? Growth Horm IGF Res. 2016;30-31):81-86.

  2. Bach LA, Fu P, Yang Z. Insulin-like growth factor-binding protein-6 and cancer. Clin. Sci. (Lond). 2013;124(4):215-229.

  3. Chen Q, Qin S, Liu Y, Hong M, Qian CN, Keller ET, Zhang J, Lu Y. IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker. Oncotarget. 2016;7(42):68 140-68 150.

  4. Galatenko VV, Shkurnikov MY, Samatov TR, Galatenko AV, Mityakina IA, Kaprin AD, Schumacher U, Tonevitsky AG. Highly informative marker sets consisting of genes with low individual degree of differential expression. Sci. Rep. 2015;5. ID 14967. doi: 10.1038/srep14967.

  5. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014;15(3):178-196.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Malaguarnera R, Belfiore A. The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells. Front. Endocrinol. (Lausanne). 2014;5:10. doi: 10.3389/fendo.2014.00010.

  7. Moreno-Bueno G, Cubillo E, Sarrió D, Peinado H, Rodríguez-Pinilla SM, Villa S, Bolós V, Jordá M, Fabra A, Portillo F, Palacios J, Cano A. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for snail, slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 2006;66(19):9543-9556.

    Article  CAS  PubMed  Google Scholar 

  8. Schwankhaus N, Gathmann C, Wicklein D, Riecken K, Schumacher U, Valentiner U. Cell adhesion molecules in metastatic neuroblastoma models. Clin. Exp. Metastasis. 2014;31(4):483-496.

    Article  CAS  PubMed  Google Scholar 

  9. Semenova OV, Petrov VA, Gerasimenko TN, Aleksandrova AV, Burmistrova OA, Khutornenko AA, Osipyants AI, Poloznikov AA, Sakharov DA. Effect of circulation parameters on functional status of HepaRG spheroids cultured in microbioreactor. Bull. Exp. Biol. Med. 2016;161(3):425-429.

    Article  CAS  PubMed  Google Scholar 

  10. Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol. Cancer. 2016;15:18. doi: https://doi.org/10.1186/s12943-016-0502-x.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Tiwari N, Meyer-Schaller N, Arnold P, Antoniadis H, Pachkov M, van Nimwegen E, Christofori G. Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8). PLoS One. 2013;8(2):e57329. doi: https://doi.org/10.1371/journal.pone.0057329.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global Cancer Statistics, 2012. CA Cancer J. Clin. 2015;65(2):87-108.

    Article  PubMed  Google Scholar 

  13. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275-292.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wang Y, Zhou BP. Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin. J. Cancer. 2011;30(9):603-611.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zeng C, Feng X, Wang W, Lv L, Fang C, Chi L, Huang L, Zhou Z. Decreased expression of insulin-like growth factor binding protein 6 is associated with gastric adenocarcinoma prognosis. Oncol. Lett. 2017;13(6):4161-4168.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Ya. Alekseev.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 11, pp. 605-610, November, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nikulin, S.V., Raigorodskaya, M.P., Poloznikov, A.A. et al. Role of IGFBP6 Protein in the Regulation of Epithelial-Mesenchymal Transition Genes. Bull Exp Biol Med 164, 650–654 (2018). https://doi.org/10.1007/s10517-018-4051-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4051-8

Key Words

Navigation